• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON TORIC UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON TORIC UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number CCW0T3
Medical Device Problem Code Scratched Material (3020)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 04/07/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Only half of the lens was returned in the lens case base.Viscoelastic was dried on the lens.The lens was cut across the center.Damage was observed around the cut area that appeared to be removal damage.The small scratch reported may have been on the half of the lens not returned.Complaint and product history records were reviewed and documentation indicated the product met release criteria.A qualified cartridge was indicated with a non-qualified handpiece.It is unknown if a qualified viscoelastic was used.The root cause for the reported "small scratch" may be related to a failure to follow the instructions for use (ifu).Only half of the lens was returned.The small scratch reported may have been on the half of the lens not returned.A non-qualified handpiece was indicated.It is unknown if a qualified viscoelastic was used.The ifu instructs: company foldable iols are qualified for use with an company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The ifu instructs that an company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.File will be reopened if new information is received.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non healthcare professional reported that, during intraocular lens implantation surgery, the surgeon noticed a small scratch and lens.Hence the lens was explanted and replaced with another lens during the same procedure with no further issues.There was no patient harm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON TORIC UV ABSORBING IOL
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
246 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
246 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key22012591
Report Number1119421-2025-01377
Device Sequence Number7883576
Product Code MJP
UDI-Device Identifier00380652431835
UDI-Public(01)00380652431835(17)261218(11)221220(10)15557335
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 05/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberCCW0T3
Device Lot Number15557335
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/23/2025
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/15/2025
Initial Report FDA Received Date05/13/2025
Date Device Manufactured12/20/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III CARTRIDGE D; PLATINUM INJECTOR
Outcome Attributed to Adverse Event Required Intervention;
Patient Age63 YR
Patient SexFemale
-
-